![]()
|
|
||||||||
J. Biol. Chem., Vol. 265, Issue 18, 10255-10259, Jun, 1990
GJ Kang, Z Getahun, A Muzaffar, A Brossi and E Hamel
Two colchicine analogs with modifications only in the C ring are better
inhibitors than colchicine of cell growth and tubulin polymerization.
Radiolabeled thiocolchicine (with a thiomethyl instead of a methoxy group
at position C-10) and N-acetylcolchinol O-methyl ether (NCME) (with a
methoxy-substituted benzenoid instead of the methoxy- substituted tropone C
ring) were prepared for comparison with colchicine. Scatchard analysis
indicated a single binding site with KD values of 1.0-2.3 microM.
Thiocolchicine was bound 2-4 times as rapidly as colchicine, but the
activation energies of the reactions were nearly identical (18 kcal/mol for
colchicine, 20 kcal/mol for thiocolchicine). NCME bound to tubulin in a
biphasic reaction. The faster phase was 60 times as fast as colchicine
binding at 37 degrees C, and a substantial reaction occurred at 0 degrees
C. The rate of the faster phase of NCME binding changed relatively little
as a function of temperature, so the activation energy was only 7.0
kcal/mol. Dissociation reactions were also evaluated, and at 37 degrees C
the half-lives of the tubulin-drug complexes were 11 min for NCME, 24 h for
thiocolchicine, and 27 h for colchicine. Relative dissociation rates as a
function of temperature varied little among the drug complexes. Activation
energies for the dissociation reactions were 30 kcal/mol for
thiocolchicine, 27 kcal/mol for NCME, and 24 kcal/mol for colchicine.
Comparison of the activation energies of association and dissociation
yielded free energies for the binding reactions of -20 kcal/mol for NCME,
-10 kcal/mol for thiocolchicine, and -6 kcal/mol for colchicine. The
greater effectiveness of NCME and thiocolchicine as compared with
colchicine in biological assays probably derives from their more rapid
binding to tubulin and the lower free energies of their binding reactions.
N-acetylcolchinol O-methyl ether and thiocolchicine, potent analogs of colchicine modified in the C ring. Evaluation of the mechanistic basis for their enhanced biological properties
Laboratory of Biochemical Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Micheletti, M. Poli, P. Borsotti, M. Martinelli, B. Imberti, G. Taraboletti, and R. Giavazzi Vascular-targeting Activity of ZD6126, a Novel Tubulin-binding Agent Cancer Res., April 1, 2003; 63(7): 1534 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Davis, G. J. Dougherty, D. C. Blakey, S. M. Galbraith, G. M. Tozer, A. L. Holder, M. A. Naylor, J. Nolan, M. R. L. Stratford, D. J. Chaplin, et al. ZD6126: A Novel Vascular-targeting Agent That Causes Selective Destruction of Tumor Vasculature Cancer Res., December 15, 2002; 62(24): 7247 - 7253. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Verdier-Pinard, Z. Wang, A. K. Mohanakrishnan, M. Cushman, and E. Hamel A Steroid Derivative with Paclitaxel-Like Effects on Tubulin Polymerization Mol. Pharmacol., March 1, 2000; 57(3): 568 - 575. [Abstract] [Full Text] |
||||
![]() |
P. Verdier-Pinard, J.-Y. Lai, H.-D. Yoo, J. Yu, B. Marquez, D. G. Nagle, M. Nambu, J. D. White, J. R. Falck, W. H. Gerwick, et al. Structure-Activity Analysis of the Interaction of Curacin A, the Potent Colchicine Site Antimitotic Agent, with Tubulin and Effects of Analogs on the Growth of MCF-7 Breast Cancer Cells Mol. Pharmacol., January 1, 1998; 53(1): 62 - 76. [Abstract] [Full Text] |
||||
![]() |
G. Chakrabarti, S. Sengupta, and B. Bhattacharyya Thermodynamics of Colchicinoid-Tubulin Interactions J. Biol. Chem., February 9, 1996; 271(6): 2897 - 2901. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bai, D. G. Covell, X.-F. Pei, J. B. Ewell, N. Y. Nguyen, A. Brossi, and E. Hamel Mapping the Binding Site of Colchicinoids on beta -Tubulin. 2-CHLOROACETYL-2-DEMETHYLTHIOCOLCHICINE COVALENTLY REACTS PREDOMINANTLY WITH CYSTEINE 239 AND SECONDARILY WITH CYSTEINE 354 J. Biol. Chem., December 15, 2000; 275(51): 40443 - 40452. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |